Imara Closes a $63MM Series B Cross-Over Financing
-Proceeds to Advance IMR-687 for the Treatment of Sickle Cell Disease (SCD) and Thalassemia, and Expand Company Pipeline -New Investors:…
Pharmaceuticals, Biotechnology and Life Sciences
-Proceeds to Advance IMR-687 for the Treatment of Sickle Cell Disease (SCD) and Thalassemia, and Expand Company Pipeline -New Investors:…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class…
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class…
DUBLIN–(BUSINESS WIRE)–The “Insulin Intelligence Center 2012-2023” report has been added to ResearchAndMarkets.com’s offering. The Insulin Intelligence Center is a global…
DUBLIN–(BUSINESS WIRE)–The “Insulin Intelligence Center 2012-2023” report has been added to ResearchAndMarkets.com’s offering. The Insulin Intelligence Center is a global…
CAMBRIDGE, England & BOSTON, Mass.–(BUSINESS WIRE)–Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary…
MARTINEZ, Calif.–(BUSINESS WIRE)–ExThera Medical Corporation (ExThera) today announced Dr. Stefan Büttner, a senior staff member of the Department of Nephrology,…
FREMONT, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/STOs?src=hash" target="_blank"gt;#STOslt;/agt;–Verseon is launching a security token offering (STO) aiming to set a new standard for the…
Proceeds will be used to advance clinical development of lead product candidate, KarXT, for additional indications beyond the ongoing Phase…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/STOs?src=hash" target="_blank"gt;#STOslt;/agt;–BlockRules, the blockchain fintech company enforcing complex compliance rules directly on the blockchain, today announces that the…